Coronado Biosciences (CNDO) Shares Surge 60%

Coronado Biosciences, Inc. (CNDO) has been a solid gainer in late morning trading, up more than 62% from Wednesday’s close of $3.22. The gains have been aided by the company’s announcement of an exclusive license agreement with NeuPharma to develop and commercialize novel irreversible, 3rd Generation EGFR inhibitors on a worldwide basis outside of certain […] View the full post at: Coronado Biosciences (CNDO) Shares Surge 60% Related posts: Atlas Pipeline (APL) Shares Soar On Nat Gas Asset Sale Broadcom Gaining Ground In Smartphone Market, Shares May See 40% Upside Insider Selling: Twitter (TWTR) CEO Unloads $5M Worth of Stock